Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 9476Triple Negative Breast Neoplasms 635Neoplasms 413Lung Neoplasms 342Prostatic Neoplasms 321Ovarian Neoplasms 299Colorectal Neoplasms 289Neoplasm Metastasis 280Motor Activity 267Carcinoma, Intraductal, Noninfiltrating 231Colonic Neoplasms 193Breast Neoplasms, Male 172Lymphedema 170Melanoma 158Pancreatic Neoplasms 152Breast Carcinoma In Situ 151Carcinoma, Non-Small-Cell Lung 149Uterine Cervical Neoplasms 144Fatigue 140Head and Neck Neoplasms 132Pain 122Breast Cancer Female 122Brain Neoplasms 118Stomach Neoplasms 117Sarcoma 106Depression 105Breast Cancer Lymphedema 101Anxiety Disorders 101Lymphoma 96Cardiotoxicity 89

Interventions

ribociclib 1Tretinoin 1Letrozole 1Goserelin 1Drug Therapy 1Chemotherapy, Adjuvant 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × HER2 Negative Breast Cancer × Breast × Clear all
NCT06953882 2026-05-26

SELECT

Yale University

Phase 2 Recruiting
140 enrolled
Breast

HER2 Negative Breast Cancer

NCT06731140 2025-11-17

Resilire

Fudan University

Phase 2 Recruiting
10 enrolled
Breast

HER2 Negative Breast Cancer

NCT03568448 2025-05-22

Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging

New Mexico Cancer Research Alliance

Active not recruiting
30 enrolled
Breast

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡